- Details
- Written by Diana Harvey
- Category: Health News
Durham, North Carolina - A long-term study of mother-child pairs in Pakistan has found that the children turn out pretty much the same, whether or not their mothers received treatment for depression during pregnancy.
- Details
- Written by AHA
- Category: Health News
Dallas, Texas - A vaccine may one day help lower blood pressure for up to six months, according to new research in the American Heart Association’s journal Hypertension.
- Details
- Written by IVN
- Category: Health News
Atlanta, Georgia - On Sunday, June 7, thousands of people in communities across the country and around the world will hold celebrations to honor cancer survivors and celebrate life on the 28thAnnual National Cancer Survivors Day®. The celebrations will call attention to the ongoing challenges of cancer survivorship and show that life after a cancer diagnosis can be rewarding and inspiring.
- Details
- Written by Marin Hedin
- Category: Health News
Baltimore, Maryland - Reporting on their study with lab-grown human cells, researchers at The Johns Hopkins University and the University of Maryland say that blocking a second blood vessel growth protein, along with one that is already well-known, could offer a new way to treat and prevent a blinding eye disease caused by diabetes.
- Details
- Written by IVN
- Category: Health News
Washington, DC - A major international randomized clinical trial has found that HIV-infected individuals have a considerably lower risk of developing AIDS or other serious illnesses if they start taking antiretroviral drugs sooner, when their CD4+ T-cell count—a key measure of immune system health—is higher, instead of waiting until the CD4+ cell count drops to lower levels. Together with data from previous studies showing that antiretroviral treatment reduced the risk of HIV transmission to uninfected sexual partners, these findings support offering treatment to everyone with HIV.
- Details
- Written by Paul Scotti
- Category: Health News
Chicago. Illinois - Because of the significant benefit found in combining the targeted drug ibrutinib with standard chemotherapy for relapsed chronic lymphocytic leukemia (CLL) or small lymphocytic lymphoma (SLL), an interim analysis has closed the international HELIOS phase III clinical trial.
Page 267 of 374
